Zealand Pharma and Boehringer Ingelheim’s weight-loss drug meets goals in mid-stage trial
Denmark's Zealand Pharma and Boehringer Ingelheim said their experimental obesity treatment achieved up to 14.9% weight loss in a mid-stage trial, lining up a...